Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-17
1996-08-20
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514872, A61K 31445
Patent
active
055479642
ABSTRACT:
The present invention relates to the use of certain tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis.
REFERENCES:
patent: 4031226 (1977-06-01), Soudijn
patent: 4066772 (1978-01-01), Vandenberk
patent: 5102667 (1992-04-01), Dubroeucq et al.
Tattersall et al., European Journal of Pharmacology, 250, No. 1, Nov. 1993, pp. R5-R6.
Bountra et al., European Journal of Pharmacology, 249, No. 1, Nov. 1993, pp. R3-R4.
Niel, Archives Internationales de Physiologie, de Biochimie et de Biophysique, 99, No. 5, 1991, pp. A65-A76.
Newton et al., J. Comp. Neurol., 234, 87-104, 1985.
Lesley, Neurochem. Int., 7, 191-211, 1985.
Andrews et al., TIPS, 9, 334-341, 1988.
Carpenter et al., Cell. and Mol. Neurobiol., 3, 113-126, 1983.
Carpenter et al., Fed. Prod. Am. Soc. Exp. Biol., 43, 2952-2954, 1984.
Saffroy et al., Peptides, 9, 227-241, 1988.
Bunce Keith T.
Hagan Russell M.
Glaxo Group Limited
Jordan Kimberly
LandOfFree
Medical use for tachykinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical use for tachykinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical use for tachykinin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2330969